Antihyperglycemic and Antihyperlipidemic Effect of Chronic Administration of Hesperetin in Diabetic Rats

BACKGROUND AND OBJECTIVE: Diabetes mellitus is one of the most important risk factors for incidence of nephropathy, retinopathy, neuropathy, and cardiovascular disorders. Use of medicinal plants and their effective constituents for attenuation of hyperglycemia and restoration of lipids to normal lev...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	M Roghani, P Baluchnejadmojarad, F Roghani-Dehkordi
Formato:	article
Lenguaje:	EN FA
Publicado:	Babol University of Medical Sciences 2010
Materias:	hesperetin diabetes mellitus antihyperglycemic antihyperlipidemic Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/0391c6589f904a959632802389b4dee6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0391c6589f904a959632802389b4dee6
record_format	dspace
spelling	oai:doaj.org-article:0391c6589f904a959632802389b4dee62021-11-10T09:00:36ZAntihyperglycemic and Antihyperlipidemic Effect of Chronic Administration of Hesperetin in Diabetic Rats1561-41072251-7170https://doaj.org/article/0391c6589f904a959632802389b4dee62010-10-01T00:00:00Zhttp://jbums.org/article-1-3663-en.htmlhttps://doaj.org/toc/1561-4107https://doaj.org/toc/2251-7170BACKGROUND AND OBJECTIVE: Diabetes mellitus is one of the most important risk factors for incidence of nephropathy, retinopathy, neuropathy, and cardiovascular disorders. Use of medicinal plants and their effective constituents for attenuation of hyperglycemia and restoration of lipids to normal level is very important. In this study, the effect of chronic administration of favonoid hesperetin on serum glucose and lipids in diabetic rats was investigated. METHODS: In this experimental study, male Wistar rats (n=40) (250-270 g) were divided into 5 groups, i.e. control, hesperetin-treated control, diabetic, and hesperetin- or glibenclamide-treated diabetic groups. For induction of diabetes, streptozotcin (STZ) was administered (60 mg/Kg i.p.). Hesperetin was administered i.p. at a dose of 10 mg/kg one week after diabetes induction for 6 weeks. Serum glucose, triglyceride, total cholesterol, LDL- and HDL- cholesterol levels were determined before the study, and at 3rd and 6th weeks after the study and compared.FINDINGS: There was a significant reduction in serum glucose level at 3rd and 6th weeks (20.1% and 23.6% respectively) in hesperetin-treated diabetic group as compared to untreated diabetics (p<0.05). In addition, there was a significant reduction for serum total cholesterol in hesperetin-treated diabetic group as compared to untreated diabetics (20.4% and 17.1% respectively) (p<0.05). Regarding serum triglyceride, there was only a non-significant reduction (11.7%) in hesperetin-treated diabetic group as compared to untreated diabetics at 6th week. On the other hand, hesperetin administration did not significantly increase HDL-cholesterol level in treated diabetics at 6th week and in contrast significantly reduced LDL-cholesterol level (29.2%) relative to untreated diabetics (p<0.05). CONCLUSION: Chronic administration of hesperetin had a significant antihyperglycemic effect and lowers serum total cholesterol and LDL-cholesterol and these changes are time-independent.M RoghaniP BaluchnejadmojaradF Roghani-DehkordiBabol University of Medical Sciencesarticlehesperetindiabetes mellitusantihyperglycemicantihyperlipidemicMedicineRMedicine (General)R5-920ENFAMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, Vol 12, Iss 4, Pp 21-26 (2010)
institution	DOAJ
collection	DOAJ
language	EN FA
topic	hesperetin diabetes mellitus antihyperglycemic antihyperlipidemic Medicine R Medicine (General) R5-920
spellingShingle	hesperetin diabetes mellitus antihyperglycemic antihyperlipidemic Medicine R Medicine (General) R5-920 M Roghani P Baluchnejadmojarad F Roghani-Dehkordi Antihyperglycemic and Antihyperlipidemic Effect of Chronic Administration of Hesperetin in Diabetic Rats
description	BACKGROUND AND OBJECTIVE: Diabetes mellitus is one of the most important risk factors for incidence of nephropathy, retinopathy, neuropathy, and cardiovascular disorders. Use of medicinal plants and their effective constituents for attenuation of hyperglycemia and restoration of lipids to normal level is very important. In this study, the effect of chronic administration of favonoid hesperetin on serum glucose and lipids in diabetic rats was investigated. METHODS: In this experimental study, male Wistar rats (n=40) (250-270 g) were divided into 5 groups, i.e. control, hesperetin-treated control, diabetic, and hesperetin- or glibenclamide-treated diabetic groups. For induction of diabetes, streptozotcin (STZ) was administered (60 mg/Kg i.p.). Hesperetin was administered i.p. at a dose of 10 mg/kg one week after diabetes induction for 6 weeks. Serum glucose, triglyceride, total cholesterol, LDL- and HDL- cholesterol levels were determined before the study, and at 3rd and 6th weeks after the study and compared.FINDINGS: There was a significant reduction in serum glucose level at 3rd and 6th weeks (20.1% and 23.6% respectively) in hesperetin-treated diabetic group as compared to untreated diabetics (p<0.05). In addition, there was a significant reduction for serum total cholesterol in hesperetin-treated diabetic group as compared to untreated diabetics (20.4% and 17.1% respectively) (p<0.05). Regarding serum triglyceride, there was only a non-significant reduction (11.7%) in hesperetin-treated diabetic group as compared to untreated diabetics at 6th week. On the other hand, hesperetin administration did not significantly increase HDL-cholesterol level in treated diabetics at 6th week and in contrast significantly reduced LDL-cholesterol level (29.2%) relative to untreated diabetics (p<0.05). CONCLUSION: Chronic administration of hesperetin had a significant antihyperglycemic effect and lowers serum total cholesterol and LDL-cholesterol and these changes are time-independent.
format	article
author	M Roghani P Baluchnejadmojarad F Roghani-Dehkordi
author_facet	M Roghani P Baluchnejadmojarad F Roghani-Dehkordi
author_sort	M Roghani
title	Antihyperglycemic and Antihyperlipidemic Effect of Chronic Administration of Hesperetin in Diabetic Rats
title_short	Antihyperglycemic and Antihyperlipidemic Effect of Chronic Administration of Hesperetin in Diabetic Rats
title_full	Antihyperglycemic and Antihyperlipidemic Effect of Chronic Administration of Hesperetin in Diabetic Rats
title_fullStr	Antihyperglycemic and Antihyperlipidemic Effect of Chronic Administration of Hesperetin in Diabetic Rats
title_full_unstemmed	Antihyperglycemic and Antihyperlipidemic Effect of Chronic Administration of Hesperetin in Diabetic Rats
title_sort	antihyperglycemic and antihyperlipidemic effect of chronic administration of hesperetin in diabetic rats
publisher	Babol University of Medical Sciences
publishDate	2010
url	https://doaj.org/article/0391c6589f904a959632802389b4dee6
work_keys_str_mv	AT mroghani antihyperglycemicandantihyperlipidemiceffectofchronicadministrationofhesperetinindiabeticrats AT pbaluchnejadmojarad antihyperglycemicandantihyperlipidemiceffectofchronicadministrationofhesperetinindiabeticrats AT froghanidehkordi antihyperglycemicandantihyperlipidemiceffectofchronicadministrationofhesperetinindiabeticrats
_version_	1718440251364474880

Antihyperglycemic and Antihyperlipidemic Effect of Chronic Administration of Hesperetin in Diabetic Rats

Ejemplares similares